glp 1 agonists and sglt2 inhibitors SGLT-2 GLP-1 Agonists: First-Line Therapy for Diabetes With Established Cardiovascular Disease Complementary Yet Distinct Roles of
Description
GLP-1RAs are not a monolithic entity but a diverse class of drugs with distinct structures and pharmacokinetic profiles

2 Department of Pharmaceutical Sciences, State University of New York, Buffalo, NY, 14214, USA

The key difference is potency and duration: the natural hormone is quickly broken down by the body, whereas synthetic medications are much more resistant to breakdown, allowing them to stay active in your system for days or even weeks

The brain needs sugar (glucose) for energy, just like a car needs gas

Taveira TH, Wu WC, Tschibelu E, Borsook D, Simonson DC, Yamamoto R, et al

For women in perimenopause and menopause, dosing decisions should follow a structured evaluation
